Quarterly report pursuant to sections 13 or 15(d)

Condensed Statements of Operations

v2.4.0.8
Condensed Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues:    
Products $ 108,500 $ 132,897
Royalties 0 25,000
Grants 182,595 222,238
Total revenue 291,095 380,135
Cost of revenues:    
Products 197,411 195,957
Grant research and development costs 202,883 233,331
Total cost of revenue 400,294 429,288
Gross loss (109,199) (49,153)
Operating expenses:    
General and administrative 744,968 351,862
Research and development 306,493 234,350
Sales and marketing 268,219 105,709
Total operating expenses 1,319,680 691,921
Loss from operations (1,428,879) (741,074)
Interest (income) expense, net (including amortization of debt discount of $1,037,386 for the three months ended March 31, 2013) (8,137) 1,083,429
Net loss $ (1,420,742) $ (1,824,503)
Net loss per share - basic and fully diluted (in dollars per share) $ (0.20) $ (1.23)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 6,999,105 1,480,262